HCA Healthcare, Inc. reported adjusted earnings of $4.12 per share in the first quarter of 2022, missing analysts' expectations by 3.5%, which sparked a 21.8% decrease in its stock price. Despite a 7% year-over-year revenue growth to $14.95 billion, the company also revealed a modest decline in net income and lowered its 2022 financial guidance, anticipating revenues of $59.5 to $61.5 billion. The disappointing results and revised outlook have raised concerns among investors, overshadowing HCA's recent share buyback of $2.1 billion and a quarterly cash dividend declaration.
“HCA Healthcare, Inc. · reported · first-quarter 2022 adjusted earnings · $4.12 per share”
“HCA Healthcare, Inc. · missed · the Zacks Consensus Estimate · 3.5%”
“HCA Healthcare, Inc. · declined · bottom line · 0.5% year over year”
“HCA Healthcare, Inc. · improved · revenues · nearly 7% year over year”
“HCA Healthcare, Inc. · had · total assets · $52.2 billion”
“HCA Healthcare, Inc. · increased · total assets · 2.9% from the level at 2021 end”
“HCA Healthcare, Inc. · issued · capital expenditures · $861 million”
“HCA Healthcare, Inc. · slumped · net cash provided by operating activities · 32.3% year over year”
“HCA Healthcare, Inc. · bought back · shares · $2.1 billion”
“HCA Healthcare, Inc. · had · remaining buyback authorization · $6.5 billion”
“HCA Healthcare, Inc. · declared · quarterly cash dividend · 56 cents per share”
“HCA Healthcare, Inc. · altered · guidance for 2022 · annual revenues in the band of $59.5-$61.5 billion”